Lung damage in rheumatoid arthritis: Complex points of clinical practice


DOI: https://dx.doi.org/10.18565/therapy.2023.6.78-81

Beketova M.F., Georginova O.A., Krasnova T.N.

1) M.V. Lomonosov Moscow State University; 2) Medical Scientific and Educational Center of M.V. Lomonosov Moscow State University
Abstract. The most severe systemic manifestations of rheumatoid arthritis (RA) include interstitial lung disease, which can become a symptomatic feature of the disease. With the development of pulmonary damage in RA patients, the range of differential diagnosis should include the point of toxic effects of methotrexate used for RA treatment, as well as infectious diseases, in particular tuberculosis. The presented case demonstrates the difficulties of pulmonary lesions’ differential diagnosis in RA patients.
Keywords: interstitial lung disease, tuberculosis, methotrexate, rheumatoid arthritis
Read entire article

Literature

1. Насонов Е.Л., Ананьева Л.П., Авдеев С.Н. Интерстициальные заболевания легких при ревматоидном артрите: мультидисциплинарная проблема ревматологии и пульмонологии. Научно-практическая ревматология. 2022; 60(6): 517–534. [Nasonov E.L., Ananyeva L.P., Avdeev S.N. Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology. Nauchno-prakticheskaya revmatologiya = Scientific and Practical Rheumatology. 2022; 60(6): 517–534 (In Russ.)]. https://dx.doi.org/10.47360/1995-4484-2022-1. EDN: SQJDEM.


2. Fragoulis G.E., Nikiphorou E., Larsen J. et al. Methotrexate-associated pneumonitis and rheumatoid arthritis-interstitial lung disease: Current concepts for the diagnosis and treatment. Front Med (Lausanne). 2019; 6: 238. https://dx.doi.org/10.3389/fmed.2019.00238.


3. Distler O., Highland K.B., Gahlemann M. et al; SENSCIS Trial Investigators. Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med. 2019; 380(26): 2518–28. https://dx.doi.org/10.1056/NEJMoa1903076.


4. Lamb Y.N. Nintedanib: A review in fibrotic interstitial lung diseases. Drugs. 2021; 81(5): 575–86.https://dx.doi.org/10.1007/s40265-021-01487-0.


5. Barakat A., Grover K., Peshin R. Rituximab for pulmonary lymphomatoid granulomatosis which developed as a complication of methotrexate and azathioprine therapy for rheumatoid arthritis. Springerplus. 2014: 3: 751.https://dx.doi.org/10.1186/2193-1801-3-751.


6. Arakawa H., Yamasaki M., Kurihara Y. et al. Methotrexate-induced pulmonary injury: Serial CT findings. J Thorac Imaging. 2003; 18(4): 231–36. https://dx.doi.org/10.1097/00005382-200310000-00004.


7. Rakesh K.Y., Raj K., Kachmar V. et al. Anti-cyclic citrullinated peptide antibodies in tuberculosis and human immunodeficiency virus. Int J Adv Med. 2020; 7(5): 804–8. https://dx.doi.org/10.18203/2349-3933.ijam20201615.


8. Lima I., Oliveira R.C., Atta A. et al. Antibodies to citrullinated peptides in tuberculosis. Clin Rheumatol. 2013; 32(5): 685–87.https://dx.doi.org/10.1007/s10067-013-2173-y.


9. Nyo M.T.L., Ally M.M.T.M., Van Duuren E.M., Arendse R. Poncet’s disease in the preclinical phase of rheumatoid arthritis. Case Rep Rheumatol. 2018; 2018: 3571247. https://dx.doi.org/10.1155/2018/3571247.


10. Higashiguchi M., Matsumoto T., Kitamura T. et al. Poncet’s disease (reactive arthritis associated with tuberculosis). Intern Med. 2022; 61(21): 3245–49. https://dx.doi.org/10.2169/internalmedicine.9241-21.


11. Sharma A., Pinto B., Dogra S. et al. A case series and review of Poncet’s disease, and the utility of current diagnostic criteria.Int J Rheum Dis. 2016; 19(10): 1010–17. https://dx.doi.org/10.1111/1756-185X.12726.


About the Autors

Maria F. Beketova, resident physician at the Department of internal medicine of the Faculty of fundamental medicine, M.V. Lomonosov Moscow State University. Address: 119234, Moscow, 1 Leninskiye Gory Str.
E-mail: olga.georginova@gmail.com
ORCID: https://orcid.org/0000-0002-7542-8189
Olga A. Georginova, PhD in Medical Sciences, associate professor of the Department of internal medicine of the Faculty of fundamental medicine, M.V. Lomonosov Moscow State University, rheumatologist at the Medical Scientific and Educational Center of M.V. Lomonosov Moscow State University. Address: 119192, Moscow, 27/10 Lomonosovsky prospect Str.
E-mail: olga.georginova@gmail.com
ORCID: https://orcid.org/0000-0002-7542-8189
Tatyana N. Krasnova, PhD in Medical Sciences, associate professor, head of the Department of internal medicine of the Faculty of fundamental medicine, M.V. Lomonosov Moscow State University. Address: 119234, Moscow, 1 Leninskiye Gory Str.
E-mail: krasnovamgu@yandex.ru
ORCID: https://orcid.org/0000-0001-6175-1076


Similar Articles

Back to Content

Бионика Медиа